Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease
June 12, 2024
June 12, 2024
June 11, 2024
June 5, 2024
May 15, 2024
May 15, 2024
May 15, 2024
May 14, 2024
May 2, 2024
April 22, 2024
April 20, 2026
AxisOne combines artificial intelligence with milestone-based delivery to accelerate lab selection, tighten research execution, and close the accounta...
April 20, 2026
Membership deepens ENPICOM's commitment to advance AI and autonomous agent infrastructure for life sciences R&D ENPICOM, an innovative bioinformat...
April 20, 2026
Strategic Partnership Combines Leinco’s Manufacturing Capabilities with IHC and Spatial Biology Validated Antibody Portfolio, plus CellCarta’s CPTAC-v...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225